Exploring the Effects of Spinal Cord Stimulation in Parkinson's Disease.
Trial
N/A
Completed
March 18, 2026
Split-belt Treadmill Training for Freezing of Gait in Parkinson's Disease
Trial
N/A
Completed
March 18, 2026
Effectiveness of STIL Orthosis in PD
Trial
N/A
Completed
March 18, 2026
Digitally-enhanced, Decentralized, Multi-omics Observational Cohort
Trial
N/A
Enrolling by invitation
March 17, 2026
Toward Molecular Profiling of Parkinson's Disease in Easily Accessible Biological Matrices
Trial
N/A
Active, not recruiting
March 17, 2026
Everyday Memory Impairment in PD-related Cognitive Decline
Trial
N/A
Active, not recruiting
March 17, 2026
Intracranial Recordings to Characterize Action Regulation Mechanisms
Trial
N/A
Enrolling by invitation
March 16, 2026
Effects of a Multicomponent Protocol With Emphasis on Muscle Power Training on Bradykinesia in Individuals With Parkinson's Disease
Trial
N/A
Completed
March 16, 2026
Circuit-Based Deep Brain Stimulation for Parkinson's Disease; Udall Clinical Core
Trial
N/A
Enrolling by invitation
March 16, 2026
Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease
Trial
Phase 2
Completed
March 15, 2026
UB-312 in Patients With Synucleinopathies
Trial
Phase 1
Completed
March 15, 2026
Terazosin And Metabolic Energetics in Parkinson's Disease
Trial
Phase 2
Not yet recruiting
March 15, 2026
[18F]F-DOPA Imaging in Patients With Autonomic Failure
Trial
Phase 1
Recruiting
March 15, 2026
Optimizing Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease
Trial
N/A
Completed
March 15, 2026
Characterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease.
Trial
N/A
Recruiting
March 15, 2026
Allopregnanolone as a Regenerative Treatment for Parkinson's Disease
Trial
Phase 1
Completed
March 12, 2026
Evaluation of Neuroinduced Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients With Parkinsonism
Trial
Phase 2
Not yet recruiting
March 12, 2026
Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson's Disease
Trial
Phase 2
Completed
March 12, 2026